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Background: 
Transdermal glyceryl trinitrate (GTN) given within 6 hours of stroke onset 
improved functional outcome in a subgroup of the Efficacy of Nitric Oxide in 
Stroke (ENOS) trial. We sought to assess GTN’s effects on imaging 
characteristics in those with an ischaemic stroke. 
 
Methods: 
ENOS randomised 4011 patients with acute stroke and raised systolic blood 
pressure to transdermal GTN or no GTN within 48 hours of onset. Imaging was 
acquired at baseline and at day 7 and adjudicated by trained neuroradiologists, 
using a set proforma, blinded to treatment. Data are odds ratios (OR) with 95% 
confidence intervals (CI) adjusted for baseline prognostic factors and imaging. 
 
Results:  
58 patients who were randomised within 6 hours of onset had a final diagnosis of 
ischaemic stroke and available imaging at both baseline and day 7; 37 were 
randomised to GTN, 21 to no GTN. At day 7, loss of grey-white matter definition 
and periventricular white matter lucencies were less commonly seen in those 
randomised to GTN compared with no GTN (OR 0.20, 95%CI 0.04-0.89, 
p=0.035; OR 0.26, 95%CI 0.07-0.96, p=0.042). A non-significant tendency 
towards reduced loss of basal ganglia outline was seen in those randomised to 
GTN compared with no GTN (OR 0.14, 95%CI 0.02-1.38, p=0.09). 
 
Conclusions: 
GTN improved imaging characteristics of cerebral ischaemia at day 7 when 
administered within 6 hours of stroke onset. The ongoing Rapid Intervention 
with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) will provide 
further detail on GTN’s effects on imaging characteristics in acute stroke. 
